利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

12 条记录 (耗时 0.02 秒)

    Knitted surgical mesh
    1.
    发明授权
    Knitted surgical mesh 有权
    针织外科网

    公开(公告)号：US06287316B1

    公开(公告)日：2001-09-11

    申请号：US09277671

    申请日：1999-03-26

    申请人： Vishvaroop Agarwal ,  Robert Dougherty

    发明人： Vishvaroop Agarwal ,  Robert Dougherty

    IPC分类号： A61B1708

    CPC分类号： D04B21/12 ,  A61F2/0063 ,  A61F2002/0068 ,  D10B2509/08

    摘要： A knitted surgical mesh formed from a yarn. The knitted mesh has from 18 to 24 courses per inch and from 5 12 to 16 wales per inch, a flexibility of from 400-950 mg-cm/cm, a burst strength greater than 175 pounds per square inch, and a pore size percentage greater than 37%.

    摘要翻译： 由纱线形成的针织外科网。 针织网具有18至24个每英寸的横列和每英寸5 12至16个纵行，柔韧度为400-950mg / cm 2，爆裂强度大于175磅/平方英寸，孔径百分比 大于37％。

    Apparatus and method for determining the range of remote point light sources
    2.
    发明申请
    Apparatus and method for determining the range of remote point light sources 审中-公开
    用于确定远程点光源范围的装置和方法

    公开(公告)号：US20050206874A1

    公开(公告)日：2005-09-22

    申请号：US10805504

    申请日：2004-03-19

    申请人： Robert Dougherty

    发明人： Robert Dougherty

    IPC分类号： G01B11/02 ,  G01B11/24 ,  G01B11/30 ,  G01C3/08 ,  G02B13/00

    CPC分类号： G02B13/00 ,  G01B11/026 ,  G01C3/08

    摘要： Ranges and transverse coordinates of point light sources are estimated by forming an out-of-focus image of the point light sources using a camera. The out-of-focus image is formed such that it is imaged as a disk or ring having a bright periphery. This is conveniently achieved by taking advantage of under- or overcorrected spherical aberration in the lens, or of diffraction effects caused by the interaction of light with the aperture of the lens. Range estimates can be calculated from a size metric of the disk or ring, which in turn can be accurately determined due to its bright periphery. Range estimates can also be obtained using certain pattern matching methods.

    摘要翻译： 通过使用相机形成点光源的离焦图像来估计点光源的范围和横坐标。 离焦图像形成为使其成像为具有明亮周边的盘或环。 这通过利用透镜中的校正不足或过矫的球面像差或由光与透镜的孔的相互作用引起的衍射效应而方便地实现。 范围估计可以根据磁盘或环的尺寸度量来计算，这可以由于其明亮的周边而被精确地确定。 也可以使用某些模式匹配方法获得范围估计。

    Camera with rotating optical displacement unit
    4.
    发明授权
    Camera with rotating optical displacement unit 失效
    相机带旋转光学位移单元

    公开(公告)号：US06616347B1

    公开(公告)日：2003-09-09

    申请号：US09677223

    申请日：2000-09-29

    申请人： Robert Dougherty

    发明人： Robert Dougherty

    IPC分类号： G03B300

    CPC分类号： G03B3/00

    摘要： Ranges of objects are determined using a camera equipped with a rotating optical axis displacement unit (ODU). The ODU receives light about an offset line of sight, and displaces it to a substantially parallel camera line of sight. The displaced light is focussed onto an image sensor. Images of a scene are captures as the ODU rotates. Range information is calculated from the apparent motion of objects in the captured images.

    摘要翻译： 使用配有旋转光轴位移单元（ODU）的摄像机确定物体的范围。 ODU接收关于偏移视线的光，并将其移动到基本平行的摄像机视线。 移位的光被聚焦到图像传感器上。 当ODU旋转时，场景的图像被捕获。 范围信息是根据拍摄图像中物体的明显运动计算的。

    Meeting effectiveness indicator and method
    5.
    发明申请
    Meeting effectiveness indicator and method 有权
    会议效果指标和方法

    公开(公告)号：US20050265264A1

    公开(公告)日：2005-12-01

    申请号：US11138361

    申请日：2005-05-27

    申请人： Dean Hering ,  John Dixon ,  Robert Dougherty

    发明人： Dean Hering ,  John Dixon ,  Robert Dougherty

    IPC分类号： H04Q11/00 ,  H04Q11/04

    CPC分类号： H04Q11/04 ,  H04L65/1096 ,  H04L65/4015 ,  H04L65/403 ,  H04Q2213/13175 ,  H04Q2213/1324 ,  H04Q2213/1332

    摘要： A meeting effectiveness indicator provides information to participants of a meeting. The information includes messages that the meeting has gone off topic, and resources are being wasted. Participants within a room or local vicinity of the indicator used wired or wireless transmitters to send indications that the meeting is going off topic. Remote participants linked to a network also send indications via a network interface. Once a total number of indications reaches a warning threshold, the indicator warns the participants that the meeting is going off topic with a warning message. If additional indications are received, then the total number of indications will reach a tangent threshold, and the participants are alerted using a tangent message that the meeting is off topic.

    摘要翻译： 会议效能指标向会议的参加者提供信息。 信息包括会议已经脱离主题的消息，资源正在被浪费。 指示器内的参与者或指示器的当地附近使用有线或无线发射器发送会议正在关闭的指示。 链接到网络的远程参与者也通过网络接口发送指示。 一旦指示总数达到警告阈值，该指示器会警告与会者会议正在关闭主题并显示警告消息。 如果收到额外的指示，则指示总数将达到切线阈值，并使用切线消息来提醒参与者会议是脱离主题。

    Uridine 5'-diphosphate and analogs useful for treating lung diseases
    6.
    发明授权
    Uridine 5'-diphosphate and analogs useful for treating lung diseases 有权
    尿苷5'-二磷酸和类似物可用于治疗肺部疾病

    公开(公告)号：US6143279A

    公开(公告)日：2000-11-07

    申请号：US143297

    申请日：1998-08-28

    申请人： Richard C. Boucher, Jr. ,  Sammy Ray Shaver ,  William Pendergast ,  Benjamin Yerxa ,  Janet L. Rideout ,  Robert Dougherty ,  Dallas Croom

    发明人： Richard C. Boucher, Jr. ,  Sammy Ray Shaver ,  William Pendergast ,  Benjamin Yerxa ,  Janet L. Rideout ,  Robert Dougherty ,  Dallas Croom

    IPC分类号： A61K9/00 ,  A61K31/7042 ,  A61K31/7052 ,  A61K31/7064 ,  A61K31/7068 ,  A61K31/7072 ,  A61K45/06 ,  A61P11/00 ,  C07H19/10 ,  A61K9/12

    CPC分类号： A61K31/7068 ,  A61K31/7072 ,  A61K45/06 ,  A61K9/0073 ,  C07H19/10 ,  Y10S514/826 ,  Y10S514/851

    摘要： Compounds of Formula I: ##STR1## wherein: X.sub.1, and X.sub.2 are each independently either O.sup.- or S.sup.- ;X.sub.3 and X.sub.4 are each independently either --H or --OH, with the proviso that X.sub.3 and X.sub.4 are not simultaneously --H;R.sub.1 is selected from the group consisting of O, imido, methylene and dihalomethylene;R.sub.2 is selected from the group consisting of H, halo, alkyl, substituted alkyl, alkoxyl, nitro and azido;R.sub.3 is selected from the group consisting of H, alkyl, acyl, aryl, and arylalkyl; andR.sub.4 is selected from the group consisting of --OR', --SR', --NR', and --NR'R", wherein R' and R" are independently selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, alkoxyl, and aryloxyl, with the proviso that R' is absent when R.sub.4 is double bonded from an oxygen or sulfur atom to the carbon at the 4-position of the pyrimidine ring, are used in methods of hydrating lung mucus secretions and treating lung disorders such as cystic fibrosis, ventilator-associated pneumonia, chronic bronchitis, chronic obstructive pulmonary disorder and primary ciliary dyskinesia. Pharmaceutical compositions containing compounds of Formula I, and novel compounds of Formula I are also described.

    摘要翻译： 式I化合物：其中：X 1和X 2各自独立地为O-或S-; X 3和X 4各自独立地是-H或-OH，条件是X 3和X 4不同时为-H; R1选自O，亚氨基，亚甲基和二卤代亚甲基; R2选自H，卤素，烷基，取代的烷基，烷氧基，硝基和叠氮基; R3选自H，烷基，酰基，芳基和芳基烷基; 并且R 4选自-OR'，-SR'，-NR'和-NR'R“，其中R'和R”独立地选自H，烷基，取代的烷基 ，芳基，取代的芳基，芳基烷基，烷氧基和芳氧基，条件是当R4与氧或硫原子双键连接到嘧啶环的4-位上的碳时，R'不存在，用于 水分肺粘液分泌物和治疗肺部疾病如囊性纤维化，呼吸机相关肺炎，慢性支气管炎，慢性阻塞性肺病和原发性纤毛运动障碍。 还描述了含有式I化合物和式I的新化合物的药物组合物。

    Knitted surgical mesh
    7.
    发明授权
    Knitted surgical mesh 有权
    针织外科网

    公开(公告)号：US6090116A

    公开(公告)日：2000-07-18

    申请号：US269980

    申请日：1999-04-02

    申请人： Margaret M. D'Aversa ,  Robert Dougherty

    发明人： Margaret M. D'Aversa ,  Robert Dougherty

    IPC分类号： A61F2/00 ,  A61B17/04

    CPC分类号： A61F2/0063 ,  D04B21/16 ,  A61F2002/0068 ,  D10B2509/08

    摘要： A knitted surgical mesh formed from a yarn. The knitted mesh has from 11 to 13 courses per inch and from 8 to 10 wales per inch, a flexibility of from 10 to 16 gfcm/cm, a burst strength greater than 175 pounds per square inch, and a pore size percentage greater than 37%.

    摘要翻译： PCT No.PCT / US97 / 17987第 一九九九年四月二日 102（e）1999年4月2日PCT 1997年10月3日提交了一种由纱线形成的针织外科网。 针织网具有每英寸11至13个线程和每英寸8至10个纵行，灵活性为10至16gfcm / cm，爆裂强度大于175磅/平方英寸，孔径百分比大于37 ％。

    Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof
    8.
    发明授权
    Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof 有权
    用尿苷5'-二磷酸治疗肺部疾病的方法及其类似物

    公开(公告)号：US6022527A

    公开(公告)日：2000-02-08

    申请号：US352390

    申请日：1999-07-13

    申请人： Richard C. Boucher, Jr. ,  Sammy Ray Shaver ,  William Pendergast ,  Benjamin Yerxa ,  Janet L. Rideout ,  Robert Dougherty ,  Dallas Croom

    发明人： Richard C. Boucher, Jr. ,  Sammy Ray Shaver ,  William Pendergast ,  Benjamin Yerxa ,  Janet L. Rideout ,  Robert Dougherty ,  Dallas Croom

    IPC分类号： A61K9/00 ,  A61K31/7042 ,  A61K31/7052 ,  A61K31/7064 ,  A61K31/7068 ,  A61K31/7072 ,  A61K45/06 ,  A61P11/00 ,  C07H19/10 ,  A61K9/12

    CPC分类号： A61K31/7068 ,  A61K31/7072 ,  A61K45/06 ,  A61K9/0073 ,  C07H19/10 ,  Y10S514/826 ,  Y10S514/851

    摘要： Compounds of Formula I: ##STR1## wherein: X.sub.1, and X.sub.2 are each independently either O.sup.- or S.sup.- ;X.sub.3 and X.sub.4 are each independently either --H or --OH, with the proviso that X.sub.3 and X.sub.4 are not simultaneously --H;R.sub.1 is selected from the group consisting of O, imido, methylene and dihalomethylene;R.sub.2 is selected from the group consisting of H, halo, alkyl, substituted alkyl, alkoxyl, nitro and azido;R.sub.3 is selected from the group consisting of H, alkyl, acyl, aryl, and arylalkyl; andR.sub.4 is selected from the group consisting of --OR', --SR', --NR', and --NR'R", wherein R' and R" are independently selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, alkoxyl, and aryloxyl, with the proviso that R' is absent when R.sub.4 is double bonded from an oxygen or sulfur atom to the carbon at the 4-position of the pyrimidine ring, are used in methods of hydrating lung mucus secretions and treating lung disorders such as cystic fibrosis, ventilator-associated pneumonia, chronic bronchitis, chronic obstructive pulmonary disorder and primary ciliary dyskinesia. Pharmaceutical compositions containing compounds of Formula I, and novel compounds of Formula I are also described.

    摘要翻译： 式I化合物：其中：X 1和X 2各自独立地为O-或S-; X 3和X 4各自独立地是-H或-OH，条件是X 3和X 4不同时为-H; R1选自O，亚氨基，亚甲基和二卤代亚甲基; R2选自H，卤素，烷基，取代的烷基，烷氧基，硝基和叠氮基; R3选自H，烷基，酰基，芳基和芳基烷基; 并且R 4选自-OR'，-SR'，-NR'和-NR'R“，其中R'和R”独立地选自H，烷基，取代的烷基 ，芳基，取代的芳基，芳基烷基，烷氧基和芳氧基，条件是当R4与氧或硫原子双键连接到嘧啶环的4-位上的碳时，R'不存在，用于 水分肺粘液分泌物和治疗肺部疾病如囊性纤维化，呼吸机相关肺炎，慢性支气管炎，慢性阻塞性肺病和原发性纤毛运动障碍。 还描述了含有式I化合物和式I的新化合物的药物组合物。